In CKD-MBD, which parathyroid condition is commonly associated with vascular calcification risk?

In CKD-MBD, which parathyroid condition is commonly associated with vascular calcification risk?

• A. Primary hyperparathyroidism due to adenoma
• B. CKD-MBD with secondary or tertiary hyperparathyroidism and calcium-based phosphate binders
• C. Hypoparathyroidism after thyroidectomy
• D. Normal PTH levels

Answer: (B)

In CKD-MBD, vascular calcification risk is driven by the combination of secondary or tertiary hyperparathyroidism with the use of calcium-based phosphate binders. Chronic kidney disease causes phosphate retention and low calcitriol, which stimulates PTH release (secondary hyperparathyroidism). If this persists, the parathyroid glands can become autonomous, leading to tertiary hyperparathyroidism with ongoing PTH and mineral imbalance. Calcium-based phosphate binders add extra calcium load, increasing the calcium-phosphate product and promoting calcium deposition in vascular walls. This specific pattern—dysregulated PTH in CKD plus calcium loading from binders—best explains the vascular calcification risk. Primary hyperparathyroidism from an adenoma, hypoparathyroidism after thyroidectomy, or normal PTH levels don’t reflect this CKD-specific dysregulation and calcium burden.

In CKD-MBD, vascular calcification risk is driven by the combination of secondary or tertiary hyperparathyroidism with the use of calcium-based phosphate binders. Chronic kidney disease causes phosphate retention and low calcitriol, which stimulates PTH release (secondary hyperparathyroidism). If this persists, the parathyroid glands can become autonomous, leading to tertiary hyperparathyroidism with ongoing PTH and mineral imbalance. Calcium-based phosphate binders add extra calcium load, increasing the calcium-phosphate product and promoting calcium deposition in vascular walls. This specific pattern—dysregulated PTH in CKD plus calcium loading from binders—best explains the vascular calcification risk. Primary hyperparathyroidism from an adenoma, hypoparathyroidism after thyroidectomy, or normal PTH levels don’t reflect this CKD-specific dysregulation and calcium burden.